We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
F&G Annuities & Life
FG
$3.03B
| $820K | ﹤0.01% |
21,544
+6,191
| +40% | +$243K |
|
2052
Textron
TXT
$14.1B
| $815K | ﹤0.01% |
9,496
-28,446
| -75% | -$2.53M |
|
2053
Option Care Health
OPCH
$3.55B
| $815K | ﹤0.01% |
29,413
-114,747
| -80% | -$3.42M |
|
2054
Ingredion
INGR
$6.69B
| $814K | ﹤0.01% |
7,094
-30,933
| -81% | -$3.57M |
|
|
UCB
2055
United Community Banks
UCB
$4.27B
| $812K | ﹤0.01% |
31,875
+1,475
| +5% | +$37.6K |
|
2056
CytomX Therapeutics
CTMX
$717M
| $808K | ﹤0.01% |
661,947
+408,174
| +161% | +$812K |
|
2057
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.48B
| $806K | ﹤0.01% |
+32,143
| New | +$766K |
|
2058
CNB Financial Corp
CCNE
$1.01B
| $806K | ﹤0.01% |
39,484
-2,300
| -6% | -$44.7K |
|
|
BNY
2059
Bank of New York Mellon
BNY
$110B
| $804K | ﹤0.01% |
13,418
-782
| -6% | -$45.3K |
|
2060
i3 Verticals
IIIV
$302M
| $804K | ﹤0.01% |
36,391
-122,497
| -77% | -$2.58M |
|
2061
Gogo Inc
GOGO
$347M
| $802K | ﹤0.01% |
83,400
-57,778
| -41% | -$547K |
|
|
LONA
2062
LeonaBio Inc
LONA
$72.8M
| $801K | ﹤0.01% |
30,213
-12,348
| -29% | -$291K |
|
|
NBP
2063
NovaBridge Biosciences American Depositary Shares
NBP
$219M
| $799K | ﹤0.01% |
478,442
-97,138
| -17% | -$174K |
|
2064
SelectQuote
SLQT
$137M
| $799K | ﹤0.01% |
289,314
-124,041
| -30% | -$299K |
|
2065
Everspin Technologies
MRAM
$393M
| $797K | ﹤0.01% |
133,031
+5,453
| +4% | +$36.1K |
|
|
COOP
2066
DELISTED
Mr. Cooper
COOP
| $795K | ﹤0.01% |
9,789
+3,093
| +46% | +$249K |
|
|
RPC
2067
Ridgepost Capital
RPC
$980M
| $794K | ﹤0.01% |
+93,671
| New | +$747K |
|
2068
Vanguard Materials ETF
VAW
$3.12B
| $790K | ﹤0.01% |
+4,100
| New | +$814K |
|
2069
Henry Schein
HSIC
$9.98B
| $789K | ﹤0.01% |
12,315
+2,727
| +28% | +$192K |
|
2070
PUT
Arbor Realty Trust
ABR
$979M
| $789K | ﹤0.01% |
55,000
| – | – |
|
2071
Baker Hughes
BKR
$61.5B
| $788K | ﹤0.01% |
22,411
-24,406
| -52% | -$800K |
|
2072
RLI Corp
RLI
$6.11B
| $788K | ﹤0.01% |
+11,202
| New | +$802K |
|
2073
Preformed Line Products
PLPC
$1.99B
| $787K | ﹤0.01% |
6,321
| – | – |
|
2074
Okta
OKTA
$22.8B
| $786K | ﹤0.01% |
8,400
-332,432
| -98% | -$31.5M |
|
2075
Indivior Pharmaceuticals
INDV
$4.27B
| $783K | ﹤0.01% |
48,575
+28,312
| +140% | +$511K |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.